These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6351625)

  • 1. Antigens in ocular and cutaneous melanomas.
    Folberg R; Donoso LA; Herlyn MF; Koprowski H
    Am J Ophthalmol; 1983 Sep; 96(3):394-5. PubMed ID: 6351625
    [No Abstract]   [Full Text] [Related]  

  • 2. Surface antigenic profile of uveal melanoma lesions analysed with a panel of monoclonal antibodies directed against cutaneous melanoma.
    Carrel S; Schreyer M; Gross N; Zografos L
    Anticancer Res; 1990; 10(1):81-9. PubMed ID: 1692197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the antigenic profile of uveal melanoma lesions with anti-cutaneous melanoma-associated antigen and anti-HLA monoclonal antibodies.
    Natali PG; Bigotti A; Nicotra MR; Nardi RM; Delovu A; Segatto O; Ferrone S
    Cancer Res; 1989 Mar; 49(5):1269-74. PubMed ID: 2917356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterisation of ocular melanoma with cutaneous melanoma antibodies.
    Bomanji J; Garner A; Prasad J; Albert DM; Hungerford JL; Granowska M; Britton KE
    Br J Ophthalmol; 1987 Sep; 71(9):647-50. PubMed ID: 3311140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigenic and cellular heterogeneity of primary uveal melanomas.
    Folberg R
    Arch Ophthalmol; 1986 Jun; 104(6):795, 798-9. PubMed ID: 3487304
    [No Abstract]   [Full Text] [Related]  

  • 6. Cell surface antigens of human uveal melanoma identified by monoclonal antibodies.
    Kalafut F; Kusenda J; Novotná L; Cernák A
    Czech Med; 1988; 11(2):73-80. PubMed ID: 3137006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two antigens detected on human ocular melanomas with the mouse monoclonal antibodies 2/10SN and 10/12SN.
    Safi N; Kantor RR; Atkinson B; Moratz C; Wilt AR; Pancake S; Reba R; Mathieson BJ; Desgrez A
    Int J Cancer; 1992 Jul; 51(5):718-26. PubMed ID: 1612780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneous expression of melanoma-associated antigens in uveal melanomas.
    van der Pol JP; Jager MJ; de Wolff-Rouendaal D; Ringens PJ; Vennegoor C; Ruiter DJ
    Curr Eye Res; 1987 Jun; 6(6):757-65. PubMed ID: 3608565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Detection of surface antigens in uveal melanoma using monoclonal antibodies].
    Cernák A; Kalafut F; Kusenda J; Novotná L
    Cesk Oftalmol; 1989 May; 45(3):145-52. PubMed ID: 2743434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibodies to uveal melanoma.
    Damato BE; Campbell AM; McGuire BJ; Lee WR; Foulds WS
    Eye (Lond); 1987; 1 ( Pt 6)():686-90. PubMed ID: 3454763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA expression in a primary uveal melanoma, its cell line, and four of its metastases.
    Blom DJ; Schurmans LR; De Waard-Siebinga I; De Wolff-Rouendaal D; Keunen JE; Jager MJ
    Br J Ophthalmol; 1997 Nov; 81(11):989-93. PubMed ID: 9505825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uveal vs. cutaneous melanoma. Origins and causes of the differences.
    Belmar-Lopez C; Mancheno-Corvo P; Saornil MA; Baril P; Vassaux G; Quintanilla M; Martin-Duque P
    Clin Transl Oncol; 2008 Mar; 10(3):137-42. PubMed ID: 18321815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of immunological techniques in the diagnosis and prognosis of ocular malignant melanoma.
    Cochran AJ; Foulds WS; Damato BE; Trope GE; Morrison L; Lee WR
    Br J Ophthalmol; 1985 Mar; 69(3):171-6. PubMed ID: 3884037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human uveal melanoma expresses NG2 immunoreactivity.
    Li Y; Madigan MC; Lai K; Conway RM; Billson FA; Crouch R; Allen BJ
    Br J Ophthalmol; 2003 May; 87(5):629-32. PubMed ID: 12714409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating melanoma-associated antigens in ocular melanoma.
    Whitmore WG; Witkin SS; Ellsworth RM
    Ann Ophthalmol; 1988 Jun; 20(6):212-7. PubMed ID: 3408088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunochemistry in ophthalmo-oncology: problems and prospects].
    Iurovskaia NN; Suchkov SV
    Vestn Oftalmol; 1983; (3):70-2. PubMed ID: 6349090
    [No Abstract]   [Full Text] [Related]  

  • 17. Monoclonal antibodies to human primary uveal melanomas demonstrate tumor heterogeneity.
    Damato BE; Campbell AM; McGuire BJ; Lee WR; Foulds WS
    Invest Ophthalmol Vis Sci; 1986 Sep; 27(9):1362-7. PubMed ID: 3744725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The newest treatments for uveal melanoma.
    Luke JJ
    Clin Adv Hematol Oncol; 2019 Sep; 17(9):490-493. PubMed ID: 31549969
    [No Abstract]   [Full Text] [Related]  

  • 19. Tumor-associated antibodies in the serum of patients with uveal melanoma.
    Brownstein S; Sheikh KM; Lewis MG
    Can J Ophthalmol; 1976 Apr; 11(2):147-54. PubMed ID: 1078333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunobiology of human cutaneous melanoma.
    Cochran AJ; Wen DR; Stene M; Fairhurst MV; Hoon DS
    Prog Clin Biol Res; 1988; 256():597-618. PubMed ID: 3368501
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.